Welcome to 2024! This week we&#39;re discussing BioSpace&#39;s tenth annual list of the hottest new life sciences companies in the U.S. <a href="https://www.biospace.com/article/nextgen-class-of-2024-top-life-sciences-startups-to-watch-this-year/">NextGen Class of 2024⁠</a> includes organizations that launched between September 2022 and September 2023 with a Series A funding. 
BioSpace&#39;s Greg Slabodkin, Heather McKenzie and Tyler Patchen discuss.

Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.